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Abstract
Background: Blood culture is viewed as the golden standard for the diagnosis of sepsis but suffers from low sensitivity and
long turnaround time. LightCycler SeptiFast (LC-SF) is a real-time multiplex polymerase chain reaction test able to detect 25
common pathogens responsible for bloodstream infections within hours. We aim to assess the accuracy of LC-SF by
systematically reviewing the published studies.
Method: Related literature on Medline, Embase, and Cochrane databases was searched up to October 2012 for studies
utilizing LC-SF to diagnose suspected sepsis and that provided sufficient data to construct two-by-two tables.
Results: A total of 34 studies enrolling 6012 patients of suspected sepsis were included. The overall sensitivity and specificity
for LC-SF to detect bacteremia or fungemia was 0?75 (95% CI: 0?65–0?83) and 0?92 (95%CI:0?90–0?95), respectively. LC-SF
had a high positive likelihood ratio (10?10) and a moderate negative likelihood ratio (0?27). Specifically, LC-SF had a
sensitivity of 0?80 (95%CI: 0?70–0?88) and a specificity of 0?95(95%CI: 0?93–0?97) for the bacteremia outcome, and a
sensitivity of 0?61 (95%CI: 0?48–0?72) and a specificity of 0?99 (95%CI: 0?99–0?99) for the fungemia outcome. High
heterogeneity was found in the bacteremia outcome subgroup but not in the fungemia outcome subgroup.
Conclusion: LC-SF is of high rule-in value for early detection of septic patients. In a population with low pretest probability,
LC-SF test can still provide valuable information for ruling out bacteremia or fungemia.
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Introduction
The burden of sepsis is increasing globally. A survey conducted
in USA in 2000 revealed that there were more than 650 thousand
of cases of sepsis annually, with an average mortality rate of 18%
[1]. Another U.S. report showed that the incidence of hospitalized
patients with septicemia or sepsis had increased more than two
folds in the last decade [2].
Aside from early optimization of hemodynamics [3,4], timely
adequate empirical antibiotics are a cornerstone of the sepsis
treatment [3,5]. Empirical therapy is then adjusted by the blood
culture results, which provide information on causative microor-
ganisms and in vitro sensitivity of antibiotics. Although blood
culture has long been viewed as the gold standard test for the
diagnosis of sepsis, it suffers from low sensitivity, prolonged
turnaround time (.48 hours), and liability for contamination [6].
Efforts have been made to improve timeliness and accuracy of
sepsis diagnosis. Recent advances include the development of
novel clinical biomarkers [7,8], refined clinical criteria [9],
intricate algorithms [10], and molecular diagnostic methods [11].
The LightCycler SeptiFast Test (Roche Diagnostics, Mann-
heim, Germany) is a commercial diagnostic test utilizing real-time
multiplex polymerase chain reaction (PCR). The diagnostic probes
for PCR target the internal transcribed sequences situated between
16S and 23S bacterial ribosomal RNA as well as between 18S and
5?6S fungal ribosomal RNA [12–14]. Once the DNA of the
pathogen is extracted from the blood and amplified by the
LightCycler machine, a positive detection is recorded if the
fluorescent signal emitted by internal hybridization probes reaches
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to identify the species. Overall, LightCycler SeptiFast Test is
designed to detect 25 common pathogens (Table 1). The analytical
sensitivity reported by the manufacturer is 100 CFU/mL for
Candida glabrata, Streptococcus spp., and coagulase-negative
Staphylococcus spp., and 30 CFU/mL for the others. With its
broad range of detection, short turnaround time, and manufac-
turer-reported high sensitivity and specificity, such a molecular
method might be a promising alternative to blood culture.
Since its debut, LightCycler SeptiFast has been intensively
studied. Nevertheless, the results are inconsistent. Taken individ-
ually, the sensitivity and specificity are dotted in a wide range, yet
potentially worthwhile accuracy and benefits of LightCycler
SeptiFast. Therefore, we aim to quantitatively synthesize current
literatures by critiquing literatures, extracting data, and pooling
with meta-analysis statistical methods to determine the diagnostic
implication and significance of this method.
Methods
Our systemic review and meta-analysis conformed to the
methods and procedures recommended by Cochrane Collabora-
tion on the meta-analysis of the diagnostic tests and the PRISMA
(Preferred Reporting Items for Systematic Reviews and Meta-
Analyses) [15,16].
Search Strategy
We performed a comprehensive search of literatures on the
MEDLINE, EMBASE, and Cochrane databases to identify studies
related to clinical utilization of LightCycler SeptiFast test for
patients with suspected sepsis. We combined several search
keywords to be ‘‘(multiplex PCR OR multiplex polymerase chain
reaction OR septifast OR sepsitest OR vyoo) AND (sepsis OR
bloodstream infection OR bacteremia OR septicemia)’’ from
inception to June 2011. No language, study type or any other filter
was set. We also searched bibliographies of retrieved full-text
articles and latest reviews to include more related studies. We also
searched bibliographies of retrieved articles and latest review and
updated our search to October 2012 before the deploying of
statistical analysis.
Study Selection
We systematically included studies using predetermined inclu-
sion criteria, which included: a) evaluation of the LightCycler
SeptiFast test on blood specimens for diagnosing sepsis; and b)
comparison of the LightCycler SeptiFast test results with reference
standards, and c) sufficient information to calculate sensitivity and
specificity. We excluded reviews, case reports, comments, and
studies using the same dataset. Two authors independently
assessed all the titles and abstracts to identify studies matching
the inclusion criteria. Discrepancies on inclusion and exclusion
were resolved by consensus meeting where additional reviewers
were enrolled.
Data Extraction
We piloted a data extraction from a few eligible studies and
developed a comprehensive standardized data extraction form for
subsequent use. Extracted data included characteristics of study
design, characteristics of study patients, diagnostic method, and
reference standard. More than one reference standard were used
in many studies. We defined those using clinical criteria to
diagnose infection as clinically-documented Infection (CDI), those
using microbiological data from other specimens with or without
blood culture as laboratory-documented infection (LDI), and those
using blood culture alone as BC.
Assessment of study quality
We assessed the quality of studies using the Quality Assessment
of Diagnostic Accuracy Studies (QUADAS) instrument [17].
Data Preparation and Statistical Analysis
We used the bivariate model for diagnostic meta-analysis to
obtain weighted overall estimates of the sensitivity and specificity
[18]. The bivariate approach models the logit-transformed
sensitivity and specificity and adjusts for the negative correlation
between the sensitivity and specificity of the index test that may
arise from different thresholds used in different studies. A
hierarchical summary receiver operating characteristic (HSROC)
curve was constructed as a way to summarize the true- and false-
positive rates from different diagnostic studies [19]. The area
under the HSROC curve measures the overall accuracy of
diagnostic tests. We also performed diagnostic odds ratio (DOR)
meta-analysis. The DOR combines both positive and negative
Table 1. SeptiFastH panel: pathogens detected by SeptiFastH.
Gram-negative bacteria Gram-positive bacteria Fungal pathogens
Escherichia coli Staphylococcus aureus Candida albicans
Klebsiella pneumoniae Coagulase-negative Staphylococci{ Candida tropicalis
Klebsiella oxytoca Streptococcus pneumoniae Candida parapsilosis
Serratia marcescens Streptococcus spp.` Candida krusei
Enterobacter cloacae Enterococcus faecium Candida glabrata
Enterobacter aerogenes Enterococcus faecalis Aspergillus fumigatus
Proteus mirabilis
Pseudomonas aeruginosa
Acinetobacter baumannii
Stenotrophomonas maltophilia
{Including S. epidermidis, S. haemolyticus, S. xylosus, S. hominis, S. cohnii, S. lugdunensis, S. saprophyticus, S. saprophyticus, S. capitis, S. pasteuri, S. warneri.
`Including S. pyogenes, S. agalactiae, S. mitis, S. mutans, S. oralis, S. anginosus, S. bovis, S. constellatus, S. cristatus, S. vestibularis., S. gordonii, S. intermedius, S. milleri, S.
salivarius, S. sanguinis, S. thermophilus, S. parasanguinis.
doi:10.1371/journal.pone.0062323.t001
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quantify the extent of between-study heterogeneity by calculating
the I
2 statistics [20]. To explore the source of heterogeneity, we
defined potential relevant covariates a priori and tested these
covariates one at a time in the meta-regression model. We used
Egger’s test for funnel plot asymmetry to test possible publication
bias. Statistical analyses were conducted using STATA 11?0 (Stata
Corp, College Station, TX). All statistical tests were two-sided, and
statistical significance was defined as a P value less than 0?05.
Results
Identification of Studies
Our initial search yielded 248 citations (Appendix S1). After two
rounds of inclusion and exclusion, a total of 34 primary studies
including 6,012 patients (8,438 episodes) were eligible for analysis,
of which 1,920 episodes (22?8%) were confirmed bacterial or
fungal infection. Appendix S1 displays the literature selection
process.
Quality of the Included Studies
The studies varied in quality. Most of the study populations
were representative of the target population. The diagnostic tests
were deployed independently of the reference standards. We did
not find differential verification of outcomes in the included
studies. Because there was no unanimous standard to confirm
clinically significant systemic infection, various definitions of
reference standards were used and outcome misclassification was
likely. Furthermore, few studies clearly mention the blinded
interpretations between the LightCycler SeptiFast results and the
clinical diagnosis; therefore, incorporation bias is likely. Results of
risk of bias evaluation by QUADAS instrument were summarized
in Appendix S2.
Study Characteristics and Patient Populations
Details of the individual studies characteristics were summarized
in Table 2. Most included studies prospectively enrolled patients
with suspected sepsis from intensive care unit (ICU), emergency
department (ED), and hematology and oncology unit. Studies by
Casalta JP specifically targeted at patients with infectious
endocarditis. Most of the included studies study on adult patients,
except five studies included both children and adults and two
included neonates or children. Eighteen of the 34 included studies
reported accuracy data on bacteremia and fungemia separately.
Various criteria were used as the reference standards, which can
be grouped as three main broad categories. Ten (52?6%) studies
used the preferred combined clinical and laboratory criteria.
Seven studies (36?8%) chose to stick to the blood culture results.
The remaining two (10?5%) used other laboratory specimens
along with blood culture as the reference standard.
Diagnostic Accuracy of the LightCycler SeptiFast Test for
composite bacteremia or fungemia outcome
The pooled sensitivity and specificity estimates for combined
bacteremia and fungemia outcome were 0?75 (95% CI: 0?65–
0?83) and 0?92 (0?90–0?95), respectively (Table 3). Specificity
appears to be more consistent than sensitivity, since most tests
turned out to be negative. The overall LR+ was 10?1 (95% CI:
6?83–15?0) and the overall LR- was 0?27 (0?19–0?39), revealing a
superior rule-in value and moderate rule-out value. The area
under the HSROC curve showed high discriminative capacity
(0?93, 95% CI: 0?91–0?95), and the pooled DOR was 31?6
(95%CI: 18?9–52?9). Significant heterogeneity existed (I
2
=87?6%). Thus, pooled measures of the tests’ diagnostic accuracy
do not adequately describe the data.
Diagnostic Accuracy of the LightCycler SeptiFast Test for
bacteremia
When specifically targeting bacteremia, the accuracy of the LC-
SF test improved with decreased heterogeneity (I
2 =79?3%). The
pooled sensitivity was 0?80 (95% CI: 0?70–0?88), while pooled
specificity was 0?95 (95% CI: 0?93–0?97). The LC-SF test also has
a high rule-in value (LR+:1 5 ?9; 95%CI: 10?4–24?3) and moderate
rule-out value (LR-:0?21; 95% CI: 0?13–0?33) in detecting
bacteremia. Results of the HSROC curves analysis (AUC: 0?96,
95%CI: 0?94–0?98) and DOR (67?5, 95% CI: 32?2–141?7) also
revealed improved discrimination for the specific bacteremia
outcome as compared to a composite bacteremia or fungemia
outcome.
Diagnostic Accuracy of the LightCycler SeptiFast Test for
fungemia
The performance data for the LC-SF test in detecting fungemia
were available in 18 studies. Compared with the performance of
the LC-SF test in detecting bacteremia, the LC-SF test had a poor
sensitivity (0?61; 95% CI: 0?48–0?72) but a nearly perfect
specificity (0?99; 95%: 0?99–0?99) when detecting fungemia.
Results from the nineteen studies showed a similar trend with a
nearly perfect heterogeneity measure (I2=0). The pooled LR+
was high (LR+:6 6 ?8, 95% CI: 39?8–112), while the pooled LR-
was unacceptably poor (LR-:0?40, 95% CI: 0?29–0?54). The
results suggested the LC-SF test was only good for ruling in
fungemia. Figure 1 shows the HSROC curves for three different
outcomes and figure 2 shows the DOR from all studies for three
different outcomes in forest plots.
Subgroup Analysis
We performed subgroup analysis by restricting studies with a
similar study setting and reference standard definition. For
bacteremia outcome, pooled sensitivity estimates improved mod-
erately after restriction to adult or elderly population (0?84; 95%
CI, 0?75–0?91), to hematological or oncological unit patients
(0?83; 95% CI, 0?73–0?91), or to studies using CDI as the
reference standard (0?82; 95%CI, 0?68–0?90). Pooled sensitivity
decreased appreciably after restriction to studies using blood
culture (0?76; 95% CI, 0?53–0?90) as the sole reference standard.
In contrast to the variable value of sensitivity in different
subgroups, specificity are relatively stable in different subgroups,
which suggests the high rule-in value and unreliable rule-out value
of LC-SF test in detecting systemic bacterial infection. For
fungemia outcome, pooled sensitivity estimates improved appre-
ciably after restriction to ICU patients (0?71; 95% CI, 0?49–0?87)
or to studies using blood culture result alone as the reference
standard (0?65; 95%CI, 0?42–0?82), while decreasing appreciably
after restriction to studies using CDI (0?55; 95% CI, 0?37–0?71) as
the reference standard. The specificity and the LR+ are stable to
different subgroup analysis, suggesting the high rule-in value of
LC-SF test in detecting systemic fungal infection.
Publication Bias and meta-regression analysis
We performed meta-regression analysis to explore source of
heterogeneity and to help explain the variation after subgroup
analysis (Table 4). Meta-regression analysis yielded a relative
DOR for each pre-specified covariate in the model. We did not
find the effect estimate significantly changed by the reference
standard definition, design characteristics, study setting, and
Multiplex PCR for Detection of Pathogens in Sepsis
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Study Settings
Prevalence
(Number) Age Inclusion Criteria
Outcome
Definition Sen., Spe.
Louie RF, 2008 [26] ED, ICU, Others 0?19 (194) Adults and
elderly
Suspected sepsis LDI 0?72, 0?94
Mancini N, 2008 [27] Hematooncology 0?33 (103) Adults Febrile neutropenia BC 0?97, 0?99
Vince A, 2008 [28] ICU, Hematooncology 0?18 (38) NA Suspected sepsis after
antimicrobial therapy
BC 0?43, 0?71
Casalta JP, 2009 [29] Others 0?64 (67) NA Suspected infectious
endocarditis
CDI 0?28, 0?96
Dierkes C, 2009 [30] ICU 0?30 (100) Adults and
elderly
Suspected sepsis LDI 0?77, 0?94
Lehmann LE, 2009 [31] NA 0?21 (467) Adults and
elderly
Suspected sepsis BC 0?61, 0?81
Lodes U, 2009 [32] ICU 0?65 (258) Adults and
elderly
Suspected sepsis CDI 0?15, 0?91
Lilienfeld-Toal MV, 2009 [33] Hematooncology 0?25 (114) Adults Fever BC 0?38, 0?86
Paolucci M, 2009 [34] NA 0?24 (38) Neonates Suspected sepsis CDI 0?89, 0?97
Varani S, 2009 [35] Hematooncology 0?26 (129) Adults and
children
Suspected sepsis or
febrile neutropenia
CDI 0?76, 0?83
Westh H, 2009 [36] NA 0?13 (558) NA Suspected sepsis BC 0?78, 0?82
Avolio M, 2010 [37] ED 0?31 (144) Adults and
elderly
Suspected sepsis CDI 0?91, 0?99
Bloos F, 2010 [38] ICU 0?17 (236) Adults and
elderly
Suspected sepsis BC 0?79, 0?74
Diamante P, 2010 [39] ED 0?30 (234) NA Suspected sepsis CDI 0?86, 0?99
Lamoth F, 2010 [40] Others 0?25 (141) Adults, elderly,
and
children
Febrile neutropenia BC 0?26, 0?75
Lehmann LE, 2010 [41] ICU 0?24 (453) Adults and
elderly
Suspected sepsis CDI 0?83, 0?93
Maubon DL, 2010 [42] Hematooncology 0?45 (115) Adults and
elderly
Suspected sepsis CDI 0?51, 0?83
Regueiro BJ, 2010 [43] ICU 0?25 (105) Adults and
elderly
Suspected sepsis LDI 0?92, 0?97
Tsalik EL, 2010 [44] ED 0?85 (310) Adults and
elderly
Suspected sepsis CDI 0?20, 0?98
Wallet F, 2010 [45] ICU 0?16 (99) Adults Fever or hypothermia CDI 0?75, 0?99
Yanagihara K, 2010 [46] ICU, ED,
Hematooncology,
Others
0?07 (395) NA Suspected sepsis CDI 0?78, 0?94
Bravo D, 2011 a [47] Hematooncology 0?32 (31) Adults and
elderly
Febrile neutropenia BC 0?60, 0?95
Bravo D, 2011 b [47] ICU 0?38 (53) Adults and
elderly
Fever BC 0?55, 0?91
Josefson P, 2011 [48] Others 0?12 (1085) Adults, elderly,
and children
Suspected sepsis BC 0?38, 0?94
Kim B, 2011 [49] NA 0?37 (70) NA Suspected catheter-
related sepsis
BC 0?92, 1?00
Lucignano B, 2011 [50] ICU, ED,
Hematooncology,
Others
0?10 (1673) Children Suspected sepsis CDI 0?85, 0?92
Lodes U, 2011 [51] ICU 0?40 (151) Adults and
elderly
Suspected sepsis CDI 0?98, 0?99
Obara H, 2011 [52] ICU, ED,
Hematooncology,
Others
0?15 (78) Adults and
elderly
Suspected sepsis BC 0?92, 0?85
Grif K, 2012 [53] ICU, Hematooncology,
Others
0?25 (69) Adults Suspected sepsis CDI 0?94, 0?98
Hettwer S, 2012 [54] ED 0?45 (112) Adults and
elderly
Suspected sepsis BC 0?70, 0?92
Multiplex PCR for Detection of Pathogens in Sepsis
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bias in the overall analysis (Egger test p=0.025) and studies
targeting bacteremia (Egger test p,0.001) or targeting fungemia
(Egger test p=0.030).
Discussion
Our study was designed to assess the diagnostic accuracy of the
LC-SF test for detecting bacterial and fungal infection among
patients suspected of infection. Our meta-analysis, which included
34 studies comprising a total of 6,012 patients, provided an overall
summary of the diagnostic accuracy of the PCR methods. Overall,
SeptiFast had a high specificity with a modest and highly variable
sensitivity. For the clinicians, this means the rule-in value is higher
than the rule-out value. In the presence of a positive SeptiFast
result in a patient with suspected bacterial or fugal sepsis, a
clinician can confidently diagnose bacteremia or fungemia and
begin appropriate antimicrobial therapy, while forgoing unneces-
sary additional diagnostic testing. However, a negative SeptiFast
result has a reasonable likelihood of being false-negative and
should be confirmed by other clinical or laboratory diagnostic tests
if the result is likely to affect patient management.
On the basis of our study, the pooled LR+ of the LC-SF test to
diagnose bacterial sepsis was 15?9 (95% CI: 10?4–24?3); and the
pooled LR- was 0?21 (95% CI: 0?13–0?33), which could translate
into a positive post-test probability of 80% and a negative post-test
probability of 5% in a virtual population with the prevalence of
bacterial sepsis as 0?20 (the actual prevalence of this study was
0?19). As far as fungal sepsis was concerned, the LC-SF test had a
LR+ of 66?8 (95% CI: 39?8–112), and a LR- of 0?40 (95% CI:
0?29–0?54), which could derive a positive post-test probability of
66?8% and a negative post-test probability of 1% in a virtual
population with the prevalence of fungal sepsis as 0?02 (the actual
prevalence of this study was 0?019). These figures help us gain
further insight in their use in the clinical practice. Although the
value of the LC-SF test in ruling out either systemic bacterial or
fungal infection was not as good as that in ruling them in, the low
background prevalence of both diseases makes these test still
provide valuable rule-out information. A post-test probability as
low as 5% for bacterial sepsis may justify withholding antibiotics
treatment in selected cases whose LC-SF test is negative and
clinical manifestation and other ancillary laboratory tests do not
strongly suggest a severe infection. Likewise, although the LR- for
the LC-SF to diagnose systemic fungal infection is only 0?44, the
extremely low pretest probability of fungemia in most clinical
setting allows the negative results of LC-SF test to remain as useful
information for clinical decision. The 1% post-test probability in
patients with a negative LC-SF test for fungal infection also
justifies withholding anti-fungal therapy and searching for other
causes of clinical deterioration and repeating the microbiological
workup. If a post-test probability of negative LC-SF test of 10% is
a clinically tolerable threshold for withholding antimicrobial
treatment, the diagnostic value of LC-SF test would lose its
reference value once the pretest probability rise to 35% for
bacterial infection and 22% for fungal infection.
From the technical viewpoint, the lack of sensitivity in the LC-
SF test may be attributable to insufficient concentration of bacteria
and limited sets of primers in the diagnostic kit. Although it seems
logical to include more primers in a diagnostic kit or to draw more
blood from a patient, the blood volume allowed in a PCR machine
is limited, and drawing large amount of blood from a patient may
not be feasible, especially for pediatric or hematological patients.
Therefore, certain modification has been suggested. Pa ¨ivi T et al.
[21] raised the number of bacteria or fungi in the blood by
culturing the blood specimens 48 hours before deploying hybrid-
ization assay. Such a combination method was shown to effectively
raise the sensitivity of a multiplex PCR-based diagnostic array to
0?95 (95% CI: 0?94–0?96) and a specificity of 0?99 (95% CI: 0?98–
0?99). The cost of this strategy is the delayed turnaround time as
an additional 24 to 48 hours are required for the direct LC-SF
test. Another new technology that may address this problem may
be the broad-range PCR amplification of conserved bacterial
DNA sequences, such as the 16S ribosomal RNA (rRNA), 23S
rRNA, and 16S-23S rRNA interspace regions. Numerous studies
[22] have demonstrated that broad-range PCR of the conserved
bacterial DNA sequences generates valuable information that
complements results of time-consuming and subjective phenotypic
tests for detecting bacterial infections. When real-time PCR and
high-resolution melting analysis are adopted, broad-range ampli-
fication of bacterial DNA offers additional benefits including
minimal labor, rapid turnaround time and a reduced risk of PCR
carryover contamination.
There are three previous meta-analyses addressing the accuracy
of multiplex PCR-based microbiological diagnostic methods.
Carlo Mengoli et al. [23] reviewed literatures studying the
diagnostic accuracy of several in-house PCR methods on patients
with invasive aspergillosis and reported a pooled sensitivity of 0?88
(95% CI: 0?75–0?94) and a pooled specificity of 0?75 (95% CI:
Table 2. Cont.
Study Settings
Prevalence
(Number) Age Inclusion Criteria
Outcome
Definition Sen., Spe.
Mauro MV, 2012 [55] Hematooncology,
Others
0?41 (75) Adults, elderly,
and children
Immunocompromised patients
suspected of sepsis
CDI 0?87, 0?95
Mencacci A, 2012 [56] Others 0?81 (21) Adults and
elderly
Suspected endocarditis CDI 1?00, 0?50
Pasqualini L, 2012 [57] Others 0?13 (382) Adults and
elderly
Suspected sepsis CDI 0?68, 0?92
Rath PM, 2012 [58] NA 0?31 (225) Adults and
elderly
Suspected sepsis
after abdominal surgery
BC 0?81, 0?77
Tschiedel E, 2012 [59] ICU 0?12 (107) Adults and
children
Suspected sepsis BC 0?92, 0?85
NA= non-available. ED=Emergency Department. ICU=Intensive Care Unit. CDI=clinically documented infection. LDI=laboratory-documented infection. BC=blood
culture. Sen.=sensitivity. Spe.=specificity.
doi:10.1371/journal.pone.0062323.t002
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targeting patients with invasive candidiasis. The pooled sensitivity
was 0?95 (95% CI: 0?88–0?98), and the pooled specificity was 0?92
(95% CI: 0?88–0?95). In comparison, our results showed the
commercial LC-SF test has a lower sensitivity (0?61) but higher
specificity (0?99) than in-house kits when detecting fungal
infection. We could not calculate the pathogen-specific accuracy
data from the extracted data, but it has been shown the accuracy
of PCR methods is pathogen dependent. Pammi M [25] reviewed
literatures targeting pediatric patients and concluded the pooled
sensitivity and specificity as 0?90 (95% CI: 0?78–0?95) and 0?96
(95% CI: 0?94–0?97), respectively. In comparison, we showed a
lower sensitivity (0?75) and specificity (0?92) in our meta-analysis.
We did not have a sufficient number of pediatric studies to
perform subgroup analysis, but excluding several studies with
mixed pediatric and adult population showed raised sensitivity in
detecting bacteremia. Unless there is a head-to-head parallel
comparative study, we cannot conclude whether the accuracy of
PCR-based microbiological diagnosis varies among age groups.
Our study has strengths and limitations. This is the first systemic
review that focuses on the accuracy of commercial real-time-PCR-
based system LC-SF. Previous meta-analysis included studies using
various kinds of in-house multiplex PCR kits and the results could
not be readily generalized to current practice. Another major
strength of our study is that we extracted, analyzed, and reported
the accuracy of data on bacterial and fungal infection separately. It
turned out the accuracy profile of LC-SF test in bacterial and
fungal sepsis detection was drastically different. There are also
several limitations in our study. First, currently, there is no
evidence that LC-SF improves patient-important outcomes.
Second, the higher false-negative rate of the LC-SF test still
carries a potential adverse impact on patient safety. It is therefore
recommended that these tests should be interpreted in the context
of pre-test probability. Third, by pooling studies dealing with a
variety of sample types, clinical settings, and study populations, we
may have introduced heterogeneity. No major controllable factor
was found to explain the heterogeneity. Lastly, at present, there is
no formal cost-effectiveness analysis for the LC-SF test. If the use
Figure 1. Shows the receiver operating curve analysis of the LightCycler SeptiFast molecular diagnostic method for the detection
of bacterial and fungal infection (Figure 1.1), bacterial infection alone (Figure 1.2), and fungal infection alone (Figure 1.3). Solid line,
solid square, inner dashed line and outer dotted line represents hierarchical summary receiver operating characteristic (HSROC) curve, bivariate
summary estimate, 95% confidence ellipse, and 95% prediction ellipse. Symbol area is proportional to study size.
doi:10.1371/journal.pone.0062323.g001
Figure 2. Shows forest plot of the diagnostic odds ratios of studies using the LightCycler SeptiFast diagnostic method to detect
bacterial and fungal infection (Figure 2.1), bacterial infection alone (Figure 2.2), and fungal infection alone (Figure 2.3).
doi:10.1371/journal.pone.0062323.g002
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PLOS ONE | www.plosone.org 7 May 2013 | Volume 8 | Issue 5 | e62323of LC-SF can lead to reduction of use of broad spectrum
antibiotics at the early course of sepsis treatment, the additional
cost may prove worthwhile.
Conclusion
Based on the published studies, we conclude that the LC-SF test
has higher rule-in than rule-out diagnostic value. In populations in
which the prevalence of systemic bacterial or fungal infection is
low, the negative LC-SF test still offer useful information for
clinical decision. The major limitation of the LC-SF test is its
suboptimal sensitivity. Before newer technology is available, we
recommend clinicians combine biomarkers, clinical findings, and
the LC-SF test to enhance the diagnostic accuracy.
Supporting Information
Appendix S1 The flow chart shows the procedure used
by the current systematic review to identify studies
using the LightCycler SeptiFast molecular diagnostic
method to detect bacterial or fungal infection.
(TIF)
Appendix S2 The figure shows QUADAS (Quality As-
sessment of Diagnostic Accuracy Studies) criteria for the
included studies.
(TIF)
Checklist S1 PRISMA Checklist.
(DOC)
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Table 4. Exploration of heterogeneity in assessment of accuracy of LightCycler SeptiFast test for diagnosis of bacteremia or
fungemia.
Potential source of heterogeneity
Relative diagnostic odds ratio
(95% confidence interval) P-value
Bacteremia
Outcome definition
Clinically documented infection 2?60 (0?31–21?79) 0?35
Laboratory documented infection 5?10 (0?17–156?22) 0?32
Blood culture Reference NA
Patient group
Adult or elderly 3?29 (0?37–28?97) 0?26
Mixed adult or pediatric patients Reference NA
Setting
ICU 0?60 (0?03–10?35) 0?70
Hematologic or oncologic unit 1?63 (0?10–26?66) 0?71
Various source of patients Reference NA
Region
Europe 0?31(0?02–5?26) 0?39
Other Reference NA
Fungemia
Outcome definition
Clinically documented infection 0?40 (0?06–2?66) 0?91
Laboratory documented infection 2?96 (0?16–55?31) 0?31
Blood culture Reference NA
Patient group
Adult or elderly 0?48 (0?08–2?90) 0?89
Mixed pediatric or adult population Reference NA
Setting
ICU 0?26 (0?01–4?96) 0?53
Hematologic or oncologic unit 0?76 (0?06–9?06) 0?81
Various source of patients Reference NA
Region
Europe 1?09 (0?10–11?81) 0?63
Other Reference NA
doi:10.1371/journal.pone.0062323.t004
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